Assessment of the In Vivo Genotoxicity of New Lead Compounds to Treat Sickle Cell Disease

Assessment of the In Vivo Genotoxicity of New Lead Compounds to Treat Sickle Cell Disease

The compounds 1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl nitrate (C1), (1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl nitrate (C2), 3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzyl nitrate (C3), 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-hydroxy-benzenesulfonamide (C4), 4-(1,3-dioxo-1,3-dihydro-...

Full description

Bibliographic Details
Main Authors: Man Chin Chung, Lídia Moreira Lima, Jean Leandro dos Santos, Eliana Aparecida Varanda, Priscila Longhin Bosquesi
Format: Article
Language:English
Published: MDPI AG 2011-04-01
Series:Molecules
Subjects:
genotoxicity assay
micronucleus
sickle cell
phthalimide derivatives
Online Access:http://www.mdpi.com/1420-3049/16/4/2982/

Internet

http://www.mdpi.com/1420-3049/16/4/2982/

Similar Items